Lv31
380 积分 2021-07-02 加入
Time-dependent population PK models of single-agent atezolizumab in patients with cancer
5小时前
已完结
Application of Model‐Informed Drug Development in Dose Selection and Optimization for siRNA Therapies
10天前
已完结
A randomized phase I study of the safety and pharmacokinetics of BI 1291583 in healthy Japanese male subjects
1个月前
已完结
Pharmacokinetics of Fipaxalparant, a Small‐Molecule Selective Negative Allosteric Modulator of Lysophosphatidic Acid Receptor 1, and the Effect of Food in Healthy Volunteers
3个月前
已完结
RNA Interference With Zilebesiran for Mild to Moderate Hypertension
5个月前
已完结
Zilebesiran: A Promising Antihypertensive Therapy Inhibiting Angiotensinogen Synthesis
5个月前
已完结
Novel Pharmacological Approaches in the Treatment of Hypertension: A Focus on RNA-Based Therapeutics
5个月前
已完结
RNA Interference With Zilebesiran for Mild to Moderate Hypertension
5个月前
已完结
Blood biomarkers in Alzheimer’s disease
6个月前
已完结
Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials
6个月前
已完结
皖公网安备34019202002308
